To join a endometrial cancer clinical trial in United States, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in United States directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.

What phases are endometrial cancer trials in United States?

Active endometrial cancer trials in United States span Phase 2, Phase 1, Phase 1, Phase 2, EARLY_Phase 1, Phase 3, Phase 2, Phase 3. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.

Browse More

All United States Trials → Global endometrial cancer Trials → All Countries → All Trials →

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology

Active Trials in United States (22)

Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers

First in Human Study of TORL-1-23 in Participants With Advanced Cancer

Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors

Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease

A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas

ctDNA Testing to Inform Standard-of-Care Treatment Decisions in People With Endometrial Cancer

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

A Study of MGC026 in Participants With Advanced Solid Tumors

Endometrial Cancer Vaginal Fluid Specimen Collection Study

A Phase 1 Study of the Safety and Tolerability of CTX-10726

BP1001-A in Patients With Advanced or Recurrent Solid Tumors

A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors

CYTALUX for Intraoperative Imaging of Patients With Endometrial Cancer

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

A Study of PHST001 in Advanced Solid Tumors

Hypofractionated External Beam Radiotherapy With Adaptive Planning for Endometrial and Cervical Cancers

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

Phase I Trial Testing the Safety and Tolerability of Chemoradiation Followed by Chemotherapy + Dostarlimab for Stage IIIC, Node Positive, Endometrial Cancer

Adaptive Daily MR-Guided Adjuvant Pelvic Therapy-Endometrial Cancer

Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors

Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer

A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors

Frequently Asked Questions